Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-11-05 Acc 0001209191-21-063228

Director bought 882 shares at an average $2.72 ($2,399)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Jones James Director	2021-10-01	Purchase	+42	$2.69	$113	17,220	D
Jones James Director	2021-10-04	Purchase	+42	$2.87	$121	17,262	D
Jones James Director	2021-10-05	Purchase	+42	$2.82	$118	17,304	D
Jones James Director	2021-10-06	Purchase	+42	$2.76	$116	17,346	D
Jones James Director	2021-10-07	Purchase	+42	$2.76	$116	17,388	D
Jones James Director	2021-10-08	Purchase	+42	$2.84	$119	17,430	D
Jones James Director	2021-10-11	Purchase	+42	$2.73	$115	17,472	D
Jones James Director	2021-10-12	Purchase	+42	$2.71	$114	17,514	D
Jones James Director	2021-10-13	Purchase	+42	$2.71	$114	17,556	D
Jones James Director	2021-10-14	Purchase	+42	$2.81	$118	17,598	D
Jones James Director	2021-10-15	Purchase	+42	$2.76	$116	17,640	D
Jones James Director	2021-10-18	Purchase	+42	$2.75	$116	17,682	D
Jones James Director	2021-10-19	Purchase	+42	$2.76	$116	17,724	D
Jones James Director	2021-10-20	Purchase	+42	$2.63	$110	17,766	D
Jones James Director	2021-10-21	Purchase	+42	$2.65	$111	17,808	D
Jones James Director	2021-10-22	Purchase	+42	$2.66	$112	17,850	D
Jones James Director	2021-10-25	Purchase	+42	$2.64	$111	17,892	D
Jones James Director	2021-10-26	Purchase	+42	$2.64	$111	17,934	D
Jones James Director	2021-10-27	Purchase	+42	$2.61	$110	17,976	D
Jones James Director	2021-10-28	Purchase	+42	$2.61	$110	18,018	D
Jones James Director	2021-10-29	Purchase	+42	$2.72	$114	18,060	D
Open-market purchases · 882 sh · avg $2.72 · $2,399